Alzheimer's disease & dementia
House committees to investigate new Alzheimer's drug approval
(Healthday)—The U.S. Food and Drug Administration's controversial approval of a new Alzheimer's drug, along with its high price, is now being investigated by two House committees.
Jul 1, 2021
0
1